- Home
- HNST vs PRTA Comparison
HNST vs PRTA Comparison
Compare HNST & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNST
- PRTA
- Stock Information
- Founded
- HNST 2012
- PRTA 2012
- Country
- HNST United States
- PRTA Ireland
- Employees
- HNST N/A
- PRTA N/A
- Industry
- HNST Catalog/Specialty Distribution
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- HNST Consumer Discretionary
- PRTA Health Care
- Exchange
- HNST Nasdaq
- PRTA Nasdaq
- Market Cap
- HNST 405.0M
- PRTA 472.1M
- IPO Year
- HNST 2021
- PRTA N/A
- Fundamental
- Price
- HNST $3.64
- PRTA $9.92
- Analyst Decision
- HNST Buy
- PRTA Buy
- Analyst Count
- HNST 5
- PRTA 9
- Target Price
- HNST $6.75
- PRTA $13.14
- AVG Volume (30 Days)
- HNST 4.1M
- PRTA 785.0K
- Earning Date
- HNST 11-11-2025
- PRTA 11-11-2025
- Dividend Yield
- HNST N/A
- PRTA N/A
- EPS Growth
- HNST N/A
- PRTA N/A
- EPS
- HNST 0.06
- PRTA N/A
- Revenue
- HNST $389,783,000.00
- PRTA $10,341,000.00
- Revenue This Year
- HNST $6.68
- PRTA N/A
- Revenue Next Year
- HNST $4.81
- PRTA $602.32
- P/E Ratio
- HNST $59.92
- PRTA N/A
- Revenue Growth
- HNST 9.58
- PRTA N/A
- 52 Week Low
- HNST $3.49
- PRTA $4.32
- 52 Week High
- HNST $8.97
- PRTA $18.88
- Technical
- Relative Strength Index (RSI)
- HNST 42.48
- PRTA 55.31
- Support Level
- HNST $3.60
- PRTA $9.98
- Resistance Level
- HNST $3.86
- PRTA $10.90
- Average True Range (ATR)
- HNST 0.18
- PRTA 0.47
- MACD
- HNST -0.00
- PRTA -0.06
- Stochastic Oscillator
- HNST 28.86
- PRTA 23.93
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.